| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | President And CEO
1 company
Anzalone Christopher Richard is a Chief Executive Officer at ARROWHEAD PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 35 sells.
Estimated insider holdings value: $314.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 13,187 | $66.10 | $871,702.77 | -0.2% | -10.0% | - | |
| Dec 29, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 51,726 | $69.13 | $3,575,574.78 | -0.7% | -17.2% | - | |
| Dec 22, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 26,031 | $68.04 | $1,771,022.38 | -0.1% | -17.9% | - | |
| Dec 17, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 85,000 | $64.04 | $5,443,462.11 | -0.5% | -11.2% | - | |
| Dec 16, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 184,298 | $67.00 | $12,348,801.97 | -0.4% | -11.3% | - | |
| Apr 11, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 141,122 | $10.87 | $1,533,336.57 | -0.7% | +60.0% | +452.5% | |
| Mar 13, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 51,425 | $15.07 | $774,974.75 | -1.3% | +11.1% | +265.3% | |
| Mar 4, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 300,000 | $17.58 | $5,274,333.67 | -3.8% | -4.1% | +280.5% | |
| Jan 2, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 11,520 | $19.05 | $219,456.00 | -0.3% | -35.4% | +245.0% | |
| Dec 23, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 12,563 | $19.59 | $246,109.17 | -0.3% | -21.5% | +253.6% |